AIM: To evaluate the ability of anti-ricin A-chain antibodies, delivered intracellularly, to protect against ricin-induced cytotoxicity in RAW264.7 cells. METHODS: Anti-deglycosylated ricin A-chain antibody and RAC18 anti-ricin A-chain monoclonal antibody were delivered intracellularly by encapsulating in liposomes or via conjugation with the cell-penetrating MTS-transport peptide. RAW264.7 cells were incubated with these antibodies either before or after ricin exposure. The changes in cytotoxicity were estimated by MTT assay. Co-localization of internalized antibody and ricin was evaluated by fluorescence microscopy. RESULTS: Internalized antibodies significantly increased cell viability either before or after ricin exposure compared to the unconjugated antibodies. Fluorescence microscopy confirmed the co-localization of internalized antibodies and ricin inside the cells. CONCLUSION: Intracellular delivery of antibodies to neutralize the ricin toxin after cellular uptake supports the potential use of cell-permeable antibodies for post-exposure treatment of ricin intoxication.
AIM: To evaluate the ability of anti-ricin A-chain antibodies, delivered intracellularly, to protect against ricin-induced cytotoxicity in RAW264.7 cells. METHODS: Anti-deglycosylated ricin A-chain antibody and RAC18 anti-ricin A-chain monoclonal antibody were delivered intracellularly by encapsulating in liposomes or via conjugation with the cell-penetrating MTS-transport peptide. RAW264.7 cells were incubated with these antibodies either before or after ricin exposure. The changes in cytotoxicity were estimated by MTT assay. Co-localization of internalized antibody and ricin was evaluated by fluorescence microscopy. RESULTS: Internalized antibodies significantly increased cell viability either before or after ricin exposure compared to the unconjugated antibodies. Fluorescence microscopy confirmed the co-localization of internalized antibodies and ricin inside the cells. CONCLUSION: Intracellular delivery of antibodies to neutralize the ricin toxin after cellular uptake supports the potential use of cell-permeable antibodies for post-exposure treatment of ricin intoxication.
Authors: J M Lord; E Deeks; C J Marsden; K Moore; C Pateman; D C Smith; R A Spooner; P Watson; L M Roberts Journal: Biochem Soc Trans Date: 2003-12 Impact factor: 5.407
Authors: Seth H Pincus; Manoj Bhaskaran; Robert N Brey; Peter J Didier; Lara A Doyle-Meyers; Chad J Roy Journal: Toxins (Basel) Date: 2015-06-09 Impact factor: 4.546
Authors: Wei-Gang Hu; Junfei Yin; Damon Chau; Charles Chen Hu; Dustin Lillico; Justin Yu; Laurel M Negrych; John W Cherwonogrodzky Journal: Biomed Res Int Date: 2012-12-26 Impact factor: 3.411
Authors: K V Fernandes; N Deus-de-Oliveira; M G Godoy; Z A S Guimarães; V V Nascimento; E J T de Melo; D M G Freire; M Dansa-Petretski; O L T Machado Journal: Braz J Med Biol Res Date: 2012-08-23 Impact factor: 2.590
Authors: Syed A Ali; Sin-Yeang Teow; Tasyriq Che Omar; Alan Soo-Beng Khoo; Tan Soo Choon; Narazah Mohd Yusoff Journal: PLoS One Date: 2016-01-07 Impact factor: 3.240